Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...
The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...
TG Therapeutics is entering 2025 with investors accustomed to a beat-and-raise guidance policy and the company needs to ...
Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...
ST. CHARLES, MI — A Sanilac County woman is accused of fraudulently buying several crossbows from a St. Charles sporting goods store then trying to sell them at a Flint pawn shop. Kimberly A.
SEATTLE, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a ...
A live webcast of the Company’s presentation may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website. Source: Dianthus Therapeutics ...
ZUG, Switzerland and BOSTON – CRISPR Therapeutics (NASDAQ:CRSP), a leader in gene-based medicine development, announced today its intention to appoint Briggs Morrison, M.D., to its Board of Directors ...
ZUG, Switzerland and BOSTON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback